Case study – Target identification via Oncolines® profiling and ResidenceTimer™ Case study – Target identification via Oncolines® profiling and ResidenceTimer™ Case study – Target identification via Oncolines® profiling and ResidenceTimer™ Oncolines®2024-08-26T10:54:25+02:00
Case study – BTK inhibitor fenebrutinib Case study – BTK inhibitor fenebrutinib Case study – BTK inhibitor fenebrutinib Oncolines®2024-08-26T10:51:14+02:00
Case study – Arginase-1 Inhibitors Case study – Arginase-1 Inhibitors Case study – Arginase-1 Inhibitors Oncolines®2024-08-26T10:52:29+02:00
Case study – Characterization of TTK Inhibitors Case study – Characterization of TTK Inhibitors Case study – Characterization of TTK Inhibitors Oncolines®2024-08-26T10:52:53+02:00
Case study – BTK Inhibitor ibrutinib Case study – BTK Inhibitor ibrutinib Case study – BTK Inhibitor ibrutinib Oncolines®2024-08-26T10:52:37+02:00
